These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
271 related articles for article (PubMed ID: 16741710)
1. Geldanamycin treatment reduces neovascularization in a mouse model of retinopathy of prematurity. Kociok N; Krohne TU; Poulaki V; Joussen AM Graefes Arch Clin Exp Ophthalmol; 2007 Feb; 245(2):258-66. PubMed ID: 16741710 [TBL] [Abstract][Full Text] [Related]
2. Avastin treatment reduces retinal neovascularization in a mouse model of retinopathy of prematurity. Rabinowitz R; Priel A; Rosner M; Pri-Chen S; Spierer A Curr Eye Res; 2012 Jul; 37(7):624-9. PubMed ID: 22578253 [TBL] [Abstract][Full Text] [Related]
3. Soluble forms of EphrinB2 and EphB4 reduce retinal neovascularization in a model of proliferative retinopathy. Zamora DO; Davies MH; Planck SR; Rosenbaum JT; Powers MR Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2175-82. PubMed ID: 15914639 [TBL] [Abstract][Full Text] [Related]
4. Local injection of receptor tyrosine kinase inhibitor MAE 87 reduces retinal neovascularization in mice. Unsoeld AS; Junker B; Mazitschek R; Martin G; Hansen LL; Giannis A; Agostini HT Mol Vis; 2004 Jul; 10():468-75. PubMed ID: 15273654 [TBL] [Abstract][Full Text] [Related]
5. Intravitreal Delivery of VEGF-A Mezu-Ndubuisi OJ; Wang Y; Schoephoerster J; Falero-Perez J; Zaitoun IS; Sheibani N; Gong S Curr Eye Res; 2019 Mar; 44(3):275-286. PubMed ID: 30383455 [TBL] [Abstract][Full Text] [Related]
6. ICAM-1 depletion does not alter retinal vascular development in a model of oxygen-mediated neovascularization. Kociok N; Radetzky S; Krohne TU; Gavranic C; Liang Y; Semkova I; Joussen AM Exp Eye Res; 2009 Oct; 89(4):503-10. PubMed ID: 19482023 [TBL] [Abstract][Full Text] [Related]
7. Quantification of vascular tortuosity as an early outcome measure in oxygen induced retinopathy (OIR). Scott A; Powner MB; Fruttiger M Exp Eye Res; 2014 Mar; 120():55-60. PubMed ID: 24418725 [TBL] [Abstract][Full Text] [Related]
8. Preliminary study of retinal pathological features in preterm birth pups exposed to an animal model of oxygen-induced retinopathy in mice. Chu ZJ; Dou GR; Wang YS; Qu XJ; Zhang Y Graefes Arch Clin Exp Ophthalmol; 2013 Aug; 251(8):1937-43. PubMed ID: 23740517 [TBL] [Abstract][Full Text] [Related]
9. Celecoxib attenuates retinal angiogenesis in a mouse model of oxygen-induced retinopathy. Liu N; Chen L; Cai N Int J Clin Exp Pathol; 2015; 8(5):4990-8. PubMed ID: 26191192 [TBL] [Abstract][Full Text] [Related]
10. The effect of thalidomide on neovascularization in a mouse model of retinopathy of prematurity. Rabinowitz R; Katz G; Rosner M; Pri-Chen S; Spierer A Graefes Arch Clin Exp Ophthalmol; 2008 Jun; 246(6):843-8. PubMed ID: 18343940 [TBL] [Abstract][Full Text] [Related]
11. Pathological but not physiological retinal neovascularization is altered in TNF-Rp55-receptor-deficient mice. Kociok N; Radetzky S; Krohne TU; Gavranic C; Joussen AM Invest Ophthalmol Vis Sci; 2006 Nov; 47(11):5057-65. PubMed ID: 17065527 [TBL] [Abstract][Full Text] [Related]
12. The mechanism of CCN1-enhanced retinal neovascularization in oxygen-induced retinopathy through PI3K/Akt-VEGF signaling pathway. Di Y; Zhang Y; Yang H; Wang A; Chen X Drug Des Devel Ther; 2015; 9():2463-73. PubMed ID: 25995618 [TBL] [Abstract][Full Text] [Related]
13. The dipeptide Arg-Gln inhibits retinal neovascularization in the mouse model of oxygen-induced retinopathy. Neu J; Afzal A; Pan H; Gallego E; Li N; Li Calzi S; Caballero S; Spoerri PE; Shaw LC; Grant MB Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):3151-5. PubMed ID: 16799062 [TBL] [Abstract][Full Text] [Related]
14. Captopril and vascular endothelial growth factor in a mouse model of retinopathy. Higgins RD; Yan Y; Geng Y; Sharma J; Barr SM Curr Eye Res; 2003 Aug; 27(2):123-9. PubMed ID: 14632165 [TBL] [Abstract][Full Text] [Related]
15. Suppression of retinal neovascularization by erythropoietin siRNA in a mouse model of proliferative retinopathy. Chen J; Connor KM; Aderman CM; Willett KL; Aspegren OP; Smith LE Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1329-35. PubMed ID: 18952918 [TBL] [Abstract][Full Text] [Related]
16. Sphingosine Kinase 2 Modulates Retinal Neovascularization in the Mouse Model of Oxygen-Induced Retinopathy. Eresch J; Stumpf M; Koch A; Vutukuri R; Ferreirós N; Schreiber Y; Schröder K; Devraj K; Popp R; Huwiler A; Hattenbach LO; Pfeilschifter J; Pfeilschifter W Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):653-661. PubMed ID: 29392309 [TBL] [Abstract][Full Text] [Related]
17. Propranolol inhibition of β-adrenergic receptor does not suppress pathologic neovascularization in oxygen-induced retinopathy. Chen J; Joyal JS; Hatton CJ; Juan AM; Pei DT; Hurst CG; Xu D; Stahl A; Hellstrom A; Smith LE Invest Ophthalmol Vis Sci; 2012 May; 53(6):2968-77. PubMed ID: 22491401 [TBL] [Abstract][Full Text] [Related]
19. Effect of Guibi-Tang, a Traditional Herbal Formula, on Retinal Neovascularization in a Mouse Model of Proliferative Retinopathy. Lee YM; Lee YR; Kim CS; Jo K; Sohn E; Kim JS; Kim J Int J Mol Sci; 2015 Dec; 16(12):29900-10. PubMed ID: 26694358 [TBL] [Abstract][Full Text] [Related]
20. The role of PDGF receptor inhibitors and PI3-kinase signaling in the pathogenesis of corneal neovascularization. Dell S; Peters S; Müther P; Kociok N; Joussen AM Invest Ophthalmol Vis Sci; 2006 May; 47(5):1928-37. PubMed ID: 16639000 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]